Speakers
Diego Tellez
(Department of Physics, Universidad Distrital Francisco José de Caldas, Bogotá D.C., Colombia.)
Steven Medina
(Department of Physics, Universidad Distrital Francisco José de Caldas, Bogotá D.C., Colombia.)
Edwin Munévar
(Department of Physics, Universidad Distrital Francisco José de Caldas, Bogotá D.C., Colombia.)
J. Alfonso Leyva
(Department of Physics, Pontificia Universidad Javeriana, Bogotá D.C., Colombia.)
Description
After the discovery of neutrons, G. L. Locher proposed the idea of using neutron capture for cancer treatment - Neutron Capture Therapy (NCT). This treatment method combines either a Boron ($^{10}$B) or Gadolinium ($^{157}$Gd) labeled drug and an epithermal neutron beam suitable for neutron capture to take place within the treated tissues. With a branching ratio of approximately 94%, the $^{10}$B nuclear reaction taking place inside the cell releases gamma rays of 0.478 MeV, alpha particles of 1.47 MeV and $^{7}$Li ions of 0.64 MeV. Using GEANT4, we present in this work a study of the effects of these final-state particles on biological cells.
Primary authors
Diego Tellez
(Department of Physics, Universidad Distrital Francisco José de Caldas, Bogotá D.C., Colombia.)
Steven Medina
(Department of Physics, Universidad Distrital Francisco José de Caldas, Bogotá D.C., Colombia.)
Edwin Munévar
(Department of Physics, Universidad Distrital Francisco José de Caldas, Bogotá D.C., Colombia.)
J. Alfonso Leyva
(Department of Physics, Pontificia Universidad Javeriana, Bogotá D.C., Colombia.)
